Co announces that it received 510(k) clearance from the FDA to market the BinaxNOW Malaria Test in the United States. The BinaxNOW test is the first and only rapid malaria test available in the US.
Abbott is making its BinaxNOW COVID-19 test available to schools, pharmacies, universities and workplaces, CNBC reported Jan. 12. Since the test was authorized in August, Abbott has distributed 150 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback